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Abstract. Dystrophin, the protein product of the hu-
man Duchenne muscular dystrophy gene, exists in
skeletal muscle as a large oligomeric complex that
contains four glycoproteins of 156, 50, 43, and 35 kD
and a protein of 59 M Here, we investigated the rela-
tive abundance of each of the components of the dys-
trophin-glycoprotein complex in skeletal muscle from
normal and mdx mice, which are missing dystrophin.
Immunoblot analysis using total muscle membranes
from control and mdx mice of ages 1 d to 30 wk
found that all of the dystrophin-associated proteins
were greatly reduced (80-90%) in mdx mouse skeletal
muscle. The specificity of the loss of the dystrophin-
associated glycoproteins was demonstrated by the
finding that the major glycoprotein composition of
T
HE X-linked recessive neuromuscular disorder Du-
chenne muscular dystrophy (DMD)l is the most com-
mon and devastating of the human muscular dystro-
phies (4, 15). Dystrophin, the high molecular weight protein
product of the human DMD gene (19, 24, 25), localizes to
the cell periphery of normal skeletal muscle, while biopsy
specimens of DMD patients are characterized by a complete
absence of dystrophin (3, 5, 20, 42, 45) . The predicted pri-
mary structure of dystrophin and its subcellular localization
suggest that dystrophin is a membrane-associated cytoskele-
tal protein of the skeletal muscle sarcolemma (25). Early
histopathological events in DMD are characterized by per-
sistent skeletal muscle necrosis. In comparison, the animal
model mdx mouse (8) is also missing dystrophin (5, 19) due
to a point mutation in the dystrophin gene (38) and exhibits
necrosis of skeletal muscle fibers (39) . The absence of dys-
trophin accompanied by skeletal muscle necrosis makes the
mdx mouse an excellent model system to study how muscle
fiber necrosis is caused by the lack of dystrophin. In addi-
tion, the mdx mouse is currently being used in the develop-
ment of potential therapies for the replacement of dystro-
phin (35) .
1. Abbreviations used in thispaper: DAG, dystrophin-associated glycopro-
tein; DAP, dystrophin-associated protein; DMD, Duchenne muscular dys-
trophy; DRP, dystrophin-related protein; WGA, wheat germ agglutinin.
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skeletal muscle membranes from normal and mdx
mice was identical . Furthermore, skeletal muscle
membranes from the dystrophic dy/dy mouse exhibited
a normal density of dystrophin and dystrophin-
associated proteins. Immunofluorescence microscopy
confirmed the results from the immunoblot analysis
and showed a drastically reduced density of
dystrophin-associated proteins in mdx muscle cryosec-
tions compared with normal and dy/dy mouse muscle.
Therefore, our results demonstrate that all of the
dystrophin-associated proteins are significantly reduced
in mdx skeletal muscle and suggest that the loss of
dystrophin-associated proteins is due to the absence of
dystrophin and not due to secondary effects of muscle
fiber degradation.
Dystrophinexists in a large oligomeric complex tightly as-
sociated with four glycoproteins of 35, 43, 50, and 156 kD
and a protein component at 59 kD (9, 17). Components of
the dystrophin-glycoprotein complex are highly enriched in
the sarcolemma from rabbit skeletal muscle (34) and dystro-
phin comprises 5 % of total cytoskeletal protein of sar-
colemma (32). Recent biochemical analysis of the mem-
brane organization of the dystrophin-glycoprotein complex
revealed that the dystrophin-associated glycoproteins (DAGs)
of 35, 43, and 50 kD are integral membrane proteins (16).
Dystrophin and its SAD associated protein were found
to be cytoskeletal elements that are tightly linked to a het-
eromeric integral membrane complex, which spans the sar-
colemma membrane and binds tightly to an extracellular
glycoprotein of 156 kD (16) . These results suggest that the
membrane-spanning dystrophin-glycoprotein complex could
havean important structuralrole in the musclecell periphery.
It is known from the study of other genetic diseases in-
volving the cytoskeleton that a deficiency in a major cyto-
skeletal component can be accompanied by the loss of other
cytoskeletal components. For example, spectrin deficiency
in hereditary elliptocytosis is also associated with a reduced
abundance in protein-4.1 and minor sialoglycoproteins (1).
In view of these findings, it is important to investigate the
status of dystrophin-associated proteins (DAPs) in mdx
skeletal muscle fibers that are missing dystrophin. Previ-ously, we have shown that the dystrophin--associated glyco-
protein of apparent 156 kD (156-DAG) was significantly re-
duced in membranes from mdx mice (17) . Here, we
investigate the abundance of all the DAPs using affinity-
purified antibodies. DAPs were found to be drastically re-
duced in membranes from dystrophin-deficient mdx mouse
muscle compared with control and dy/dy mouse muscle,
which has dystrophic fibers but contains dystrophin (2). Im-
munofluorescence microscopy confirmed that the density of
DAPs is greatly reduced in skeletal muscle cryosections
from mdx mice. These data support the hypothesis that the
absence ofdystrophin leads to a deficiency in all of the com-
ponents ofthe dystrophin-glycoprotein complex and suggest
that a lack in DAPs may render skeletal muscle fibers more
susceptible to muscle cell necrosis.
Materials and Methods
Isolation ofSkeletalMuscle Membranes
Total skeletal muscle membranes were prepared from age-matched normal
control mice and mdx mice. Hind leg and back muscles were dissected and
homogenized in 7.5 vol of homogenization buffer (20 mM sodium pyro-
phosphate, 20 mM sodium phosphate monohydrate, I MM M9C12, 0.303
M sucrose, and 0.5 mM EDTA, pH 7.0) by a Polytron PTS-10-S (Kinematic
GmbH, Luzern, Switzerland) in the presence of a protease inhibitor cock-
tail (34) to minimize protein degradation. Homogenates were centrifuged
for 15 min at 1,100 g and the supernatant was filtered through four layers
of cheesecloth. The pellets from this initial centrifugation step were re-
homogenized and centrifuged as described above. The supernatants of four
repeated homogenization cycles were combined and total muscle mem-
branes were obtained by centrifugationofthe combined supernatants for35
min at 140,000 g. The final membranepreparation was KCl-washed as pre-
viouslydescribed (34) to remove actomyosin contamination. Skeletal mus-
cle membranes from control and dystrophic dy/dy mice (C57BL/6J-dy;
Jackson Laboratory Bar Harbor, ME) were prepared as described for con-
trol and mdx mouse muscle.
Purified rabbit skeletal musclesarcolemma(34) was isolatedusing apre-
viously described wheat germ agglutination (WGA) procedure and dystro-
phin-glycoprotemcomplex wasprepared fromrabbit skeletal muscle as de-
scribed (18). Protein was determined as described (36) using BSA as a
standard.
Antibodies to the Dystrophin-associatedProteins
Specific antibodies against the different components ofthe dystrophin-gly-
coprotein complex were produced in a sheep using the purified dystro-
phin-glycoprotein complex (9, 18) as previously performed with guinea
pigs (16). Subcutaneous injections of 1 ml of the native dystrophin-glyco-
proteincomplex (0.7 mgprotein) (9, 18) mixed withFreund's completeadju-
vant (Sigma Chemical Co., St. Louis, MO) were administered into a sheep
at numerous sites. 8 wk after the initial injection the animal was boosted
intravenously with 0.7 mg ofdystrophin-glycoprotein complex and 7 d later
a blood sample was taken. After testing the crude sheep antisera for the
presence of antibodies against the dystrophin-glycoprotem complex,
specific antibodies to 35-DAG, 43-DAG, 50-DAG, and 59-DAP were affin-
ity purified from individual Immobilon-P transfer membrane strips of the
various components of the dystrophin-glycoprotein complex as described
(16, 37). Specificity ofaffinity-purified antibodies was subsequently deter-
mined by immunoblot analysis with rabbit sarcolemma and rabbit dystro-
phim-glyceProtein complex.
mAbs XIXC2 to dystrophin (17), VIA41 to 156-DAG (17), IVD31 to 50-
DAG (17, 21), and McB2 to Na/K ATPase (41) were previously character-
ized by extensive immunofluorescenceand immunoblotanalysis (34). Rab-
bit polyclonal antibodies against the COOH-terminal sequences of human
dystrophin and human dystrophin-related protein (DRP) were affinity
purified and characterized as described (18, 33).
Gel ElectrophoresisandImmunoblotAnalysis
Proteins were fractionated on 3-12% gradientSDS polyacrylamidegels ac-
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cording toLaemmli (26). Protein bands werevisualized by Coomassie blue
staining and also analyzed by Stains-all staining (10). Transfer of proteins
to nitrocellulose was performed according to Towbin etal. (40) and immu-
noblot staining with antibodies as described (17). After blocking in Blotto
(5% nonfat dry milk in PBS, pH 7.4) for 2 h, immunoblots were incubated
overnight at room temperature with 1:1,000 diluted crude antisera, 1:50
diluted affinity-purified antibodies, or 1:5 diluted hybridoma supernatant.
After washing nitrocellulose membranes three times for 10 min in Blotto,
immunoblots were incubated with 1:1,000 diluted, affinity-purified, per-
oxidase-conjugated goat anti-mouse IgG or goat anti-rabbit IgG or rabbit
anti-sheep IgG (Boehringer Mannheim Corp., Indianapolis, IN). Finally
immunoblots were again washed three times in Blotto, briefly rinsed in dis-
tilled water, and then developed in 20 mM Tris-Cl, pH 7.5, 200 mM NaCl
using4-chloro-l-naphtholassubstrate(21). Densitometric scanning ofradio-
actively labeledimmunoblots was carried out on acomputing densitometer
(model 3005; Molecular Dynamics, Sunnyvale, CA) (34). After primary
labeling with sheep antibody, immunoblots of mouse muscle membranes
were incubated with 1:1000 diluted rabbit anti-sheep secondary antibody
followed by incubation with 1251-labeled protein A (-200,000 cpm/ml;
Amersham Corp., Arlington Heights, IL). This proceduregavea strong re-
producible signal in autoradiography and enabled densitometric scanning
ofantibody binding to control and mdx mouse muscle membranes. Mem-
brane preparations used for comparative purposes in autoradiography were
obtained from individual mice and not combined during the isolation pro-
cedure. Antibody staining intensity from sutoradiographs ofimmunoblots
after incubation with 125I-labeled protein A revealed a linear relationship
between the amount of membrane protein (0.05-300 kg protein) and the
relative labeling intensity of the specific antibody. Prestained molecular
weight standards were obtained from Bethesda Research Laboratories
(Gaithersburg, MD) and the apparent molecular masses were as follows:
myosin, 224 kD; phosphorylase b, 109 kD; albumin, 72 kD; ovalbumin,
46 kD; and carbonic anhydrase, 29 kD.
Lectin staining of immunoblots was carried out under optimized condi-
tions as described (9, 34). Blots were incubated for 1 h with 1:1,000diluted
peroxidase-labeled WGA, Con A (Sigma Chemical Co.), and jacalin (Vec-
tor Laboratories, Inc., Burlingame, CA) and developed in 20 mM Tris-Cl,
pH 7.5, 200 mM NaCI using 4-chloro-l-naphthol as substrate.
Immunofiuorescence Microscopy
Immunofluorescencemicroscopy of7-,umtransversecryosections from con-
trol, mdx, anddy/dy mouseskeletal muscle (gastrocnemius)was performed
as described previously (33, 34). After preincubation for 20 min with 5%
normal goat serumin PBS(50mM sodiumphosphate, pH 7.4, 0.9% NaCl),
cryosections were incubated for 1 h at 37°C with primary antibodies (affin-
ity-purified antibodies or 1:1000 dilution ofcrudeantisera). After extensive
washing in PBS the sections were labeled with 1:200 diluted, affinity-puri-
fied, fluorescein-labeled goat anti-rabbit IgG or rabbit anti-sheep IgG
(BoehringerMannheim Corp.) and subsequentlyexaminedina Zeiss Axio-
plan fluorescence microscope.
For labeling of skeletal muscle specimens with WGA, cryosections were
incubated with 1:1,000 dilutedfluorescein-conjugated WGA (Sigma Chemi-
cal Co.) for 30 min in the presence and absence of 0.3 M N-acetylglucos-
amine. Sections were extensively washed in PBS and then examined for
specific labeling in a fluorescence microscope. Histochemical examination
of control, mdx, and dy/dy mouse skeletal muscle cryosections was per-
formed by haematoxylin and eosin staining as described by Dubowitz (14).
Results
AffinityPurification ofAntibodies toDAPs
Sheep antiserum raised against the native dystrophin-glyco-
protein complex was used to affinity purify antibodies to the
individual components of the tightly associated dystro-
phin-glycoprotein complex (9, 16, 17). The immunoblot
analysis of Fig. 1 demonstrates that crude sheep antiserum
reacted with all of the components of the dystrophin-glyco-
protein complex (dystrophin, 156-DAG, 59-DAP, 50-DAG,
43-DAG, 35-DAG) in sarcolemma and purified dystrophin-
glycoprotein complex. Afteraffinity purification, sheepanti-
bodies to 35-DAG, 43-DAG, 50-DAG, and 59-DAP exhibited
1686Figure 1. Characterization of affinity-purified sheep antibodies to
DAPs. Shown are identical immunoblots labeled with crude sheep
antiserum to dystrophin-glycoprotein complex (sheep), as well as
affinity-purified sheep antibodies to DAPS 35-DAG, 43-DAG, 50-
DAG, and 59-DAP and mAb VIA41 to 156-DAG. Lanes 1 and 2
consist of purified rabbit skeletal muscle sarcolemma (50 Wg pro-
tein/lane) and dystrophin-glycoprotein complex, respectively. For
comparative purposes, an experimentally evaluated amount of
purified dystrophin-glycoprotein complex was chosen for lane 2 in
order to exhibit the same peroxidase staining intensity as the sar-
colemma proteins in lane 1 . All five antibodies are highly specific
for their respective antigen, which is an important prerequisite for
the comparative immunoblot analysis of skeletal muscle mem-
branes from normal, dy/dy, and mdx mice (see Figs . 2, 3, 4, and
6) . Molecular weight standards (M, x 10-3) are indicated on the
left .
strong labeling oftheir respective antigen in sarcolemma and
isolated dystrophin-glycoprotein complex from rabbit skel-
etal muscle. The results from Fig . 1 indicate the specificity
of the affinity-purified antibodies for the different compo-
nents of the dystrophin-glycoprotein complex in skeletal
muscle and this is a crucial prerequisite for the characteriza-
tion ofDAPs in control, mdx, and dy/dymouse muscle (see
Figs . 2-4 and 6) . Affinity purification of sheep antibodies to
156-DAG was complicated due to contaminating fragments
from degraded dystrophin molecules . We therefore used the
previously characterized mAb VIA41 (17, 34) for the anal-
ysis of 156-DAG, which is a highly specific probe for 156-
DAG and exhibits strong labeling in immunoblotting (34 and
Fig . 1) .
Protein and Glycoprotein Composition ofSkeletal
MuscleMembranesfrom mdxMice
To examine the status ofDAPs in mdx mouse muscle, total
membrane isolates from skeletal muscle homogenates were
prepared by a successive homogenization procedure . Total
membrane preparations exhibited a highly reproducible pro-
tein composition as judged by Coomassie blue and Stains-all
staining as well as immunoblot analysis using highly specific
antibodies for marker proteins of the various skeletal muscle
membrane systems (34) (results not shown) . Coomassie blue
staining of control and mdx membranes revealed that both
membrane preparations are very similar in overall protein
composition (Fig . 2) . Furthermore, the plasma membrane
marker Na/KATPase was found to be equally distributed in
both membrane preparations (Fig . 2), demonstrating that
both membrane preparations contained equal amounts of
Ohlendieck and Campbell Dystrophin-associated Proteins
sarcolemma . Total skeletal muscle membranes from mdx .
mice contain DRP (22, 28) in normal size and abundance as
already previously described for purified sarcolernma (33)
but lacked dystrophin (Fig. 2) . Before the examination ofthe
DAGs inmdxmouse musclewe evaluated the general status
ofglycoproteins in themembrane preparation of normal and
mdxmouse muscle using lectin staining. WGA, Con A, and
jacalin staining showed that the glycoprotein composition
with respect to these three lectins is nearly identical in con-
trol and mdx mouse muscle membranes (Fig . 2) . These
results indicate that the major glycoprotein components are
not severely affected in mdx mouse muscle . Lectin staining
is an important control experiment to account for possible
secondary effects on sarcolemma proteins caused by the on-
going degeneration and regeneration cycles in mdx skeletal
muscle fibers .
Dystrophin-associated Proteins in Skeletal Muscle
Membranesfrom mdx Mice
Identical immunoblots were examined for the relative abun-
dance of DAPs in skeletal muscle membranes from control
andmdx mice . Immunoblot analysis of normal mouse skele-
tal muscle with antibodies to DAPs demonstrated the pres-
ence ofDAPs of apparent 35, 43, 50, 59, and 156 kD (Fig.
2) as previously described for rabbit skeletal muscle (9, 16,
17) . However, the relative abundance ofall of theDAPs was
significantly reduced in mdx muscle membranes (Fig . 2) .
Although peroxidase staining showed very low levels of
DAPs in mdx skeletal muscle membranes, the exact amount
of remaining DAPs was quantitated using 1151-protein A-la-
beled immunoblots . Densitometric scanning of sutoradio-
graphs, carried out as described in Materials and Methods,
revealed an 84 f 3% reduction for 35-DAG, an 80 f 5%
reduction for 43-DAG, an 83 f 5% reduction for 50-DAG,
an 86 f 6% reduction for 59-DAP, and an 85 t 6% reduc-
tion for 156-DAG in mdx muscle membranes when com-
pared with control membranes (see Table I) . The compara-
tive densitometric scanning was performed with individually
isolated membranes from five 10-wk-old control mice and
five 10-wk-old mdx mice. The same results were obtained
with crude skeletal muscle membranes, which had not been
washed with 0.6 M KCI, and also with microsomal mem-
branes prepared as described previously (34) (results not
shown) . DAPs were reduced to a similar extent in mem-
branes isolated from l-, 3-, and 5-d-old mice (Fig . 3 a), as
well as 2-, 5-, and 30-wk-old mdx mice (Fig . 3 b) as com-
pared with age-matched control mice. The immunoblot anal-
ysis illustrated in Fig . 3 covers the time period before, dur-
ing, and after segmental necrosis in mdx skeletal muscle
fibers (39) . Dystrophin is completely lacking from mdx
skeletal muscle of all ages, while DRP was found to be pres-
ent in mdx mice of all ages (Fig . 3) . Plasma membrane
marker Na/KATPase is equally distributed in themembrane
preparations of differently aged normal and mdx mice (Fig .
3), showing that approximately equal amounts of sar-
colemma proteins are present in the individual membrane
preparations . It should be noted that 156-DAG exhibited,
with an increase in age ofmice, a slower electrophoreticmo-
bility (Fig. 3), possibly caused by the different glycosylation
of 156-DAG at different points in the development ofmouse
skeletal muscle. These findings demonstrate the specific loss
1687ofthe DAPs inmdxskeletal muscle, whilethe overall glyco-
protein composition is unaffected .
DAR in Skeletal MuscleMembranesfrom
dy1dyMouse
Themurine mutant Dystrophia muscularis dy/dy, whichhas
an autosomal-recessivemode of inheritance, is another ani-
mal model for muscular dystrophy which exhibits progres-
sive and severe degeneration of skeletal muscle fibers (6).
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Figure 2 . Immunoblot analysis
of DAPS in skeletal muscle
membranes from mdx mice .
Shown are a Coomassie blue-
stained geland identical immu-
noblots labeled with rabbit anti-
bodies to dystrophin (DYS)and
DRP,mAbMcB2 to Na/K-ATP
ase, mAb VIA4, to 156-DAG,
and affinity-purified sheep anti-
bodies to DAPS 35-DAG, 43-
DAG, 50-DAG, and 59-DAP, as
well as blots stained withWGA,
ConA, andjacalin . Lanes1and
2 consist ofmembranes prepared
from 10-wk-oldnormal andmdx
mouse skeletal muscle (250 pg
protein/lane), respectively. Both
preparations are very compara-
ble with respect to protein and
glycoprotein composition . How-
ever, in mdx skeletal muscle
membranesdystrophin is absent
and all of the DAPS are greatly
reduced when compared with
control skeletal muscle . A re-
duction of 84% for 35-DAG,
80% for 43-DAG, 83% for 50-
DAG, 86% for59-DAP, and85%
for 156-DAG was revealed by
densitometric scanning of 1151
protein A-labeled immunoblots .
Molecularweight standards(M,
x 10-3) are indicated on the left .
The genetic defect is notknown butthe genetic locus for the
neuromuscular disorder dystrophia muscularis is on mouse
chromosome 10 (7) . Histochemical examination of skeletal
muscle fibers from dy/dy mice reveal necrotic fibers (6, and
see Fig . 5 c forhaematoxylin and eosin staining of skeletal
muscle cryosections from dy/dy mouse) . Muscle mem-
branes from dy/dy mice contain dystrophin of normal size
and abundance (Fig. 4), making this animal model a very
good control for the status ofDAPs in necrotic muscle which
Table L Dystrophin-associated Proteins in Skeletal Muscle MembranesfromNormal, dy/dy, andmdx Mice
Rabbit antibodies Rb-DYS andRb-DRP are directed against the unique COOH-terminal sequences of dystrophin and dystrophin-related protein, respectively . Anti-
bodies against DAPs were affinity purified from sheep antiserum, which had been raised against the native dystrophin-glycoprotein complex .
+, Present ; - reduced (80-90%); ND, not detected ; NE, not examined .
* This study .
** No antibody to this protein has been produced .
Component M Normal
Immunoblotting
(total skeletal muscle membranes)
dy/dy mdx Ab (reference)
Dystrophin 427 kD + + ND Rb-DYS (18)
DRP >427 kD + + + Rb-DRP (33)
156-DAG 156 kD + + - VIA4, (17)
59-DAP 59 kD + + - Sh-DAP/59 (*)
50-DAG 50 kD + + - Sh-DAP/50 (*)
43-DAG 43 kD + + - Sh-DAP/43 (*)
35-DAG 35 kD + + - Sh-DAP/35 (*)
25-DAP 25 kD NE NE NEFigure 3. Immunoblot analysis ofDAPS in skeletal muscle membranes frommdx mice ofdiffering ages . Shown is a summary ofthe immuno-
blot analysis of control and mdx skeletal muscle membranes from mice of different ages . Immunoblots were stained with rabbit antibodies
to dystrophin (DYS) and DRP, mAb McB2 to Na/K-ATPase, mAb VIA41 to 156-DAG, and affinity-purified sheep antibodies toDAPs 35-
DAG, 43-DAG, 50-DAG, and 59-DAP The individual lanes consist of control andmdx skeletal muscle membranes of 1-, 3-, and 5-d-old
mice (a) and of2-, 5-, and 30-wk-old mice (b) . Membranes ofdystrophin-deficient mdx skeletal muscle from mice ofdifferent ages showed
comparable amounts of Na/K-ATPase, while all of the DAPs were found to be drastically reduced in the time period before, during, and
after segmental skeletal muscle fiber necrosis . DRP was present in control and mdx mice of all ages . Molecular weight standards (M r
x 10-3) are indicated on the left .
contains dystrophin . Coomassie blue staining revealed no
apparent differences between membranes isolated from con-
trol and dy/dy mouse skeletal muscle, and the density ofdys-
trophin and dystrophin-related protein is also comparable
between both membrane preparations (Fig . 4) . Most impor-
tantly, antibodies to the different DAPs showed approxi-
mately equal amounts of these proteins in skeletal muscle
membranes from control and dy/dy mice (Fig. 4) . These
findings demonstrate that DAPs are not affected by second-
ary events in necrotic muscle and suggest that the reduced
density of DAPs in skeletal muscle membranes from mdx
mice is probably due to the absence of dystrophin from the
membrane cytoskeleton of mdx muscle .
Distribution ofDAGs in Skeletal Musclefrom
mdx Mice
After investigating the relative abundance of DAPs in total
membranes from mdx skeletal muscle, it was important to
confirm these results in studies of whole muscle tissue . We
therefore used indirect immunofluorescence microscopy to
evaluate the status ofDAPs in skeletal muscle cryosections
from control, mdx, and dy/dy mice . Affinity-purified sheep
antibodies to DAPs exhibited strong immunofluorescence
labeling of mouse skeletal muscle . For a reproducible and
reliable comparison of all muscle samples, cryosections
were treated in an identical manner during all incubation and
washing steps . Photographs were taken under identical con-
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ditions with the same exposure time so that a direct compari-
son of immunofluorescent staining intensity could be un-
dertaken .
The upper panel of Fig . 5 shows histochemical staining of
skeletal muscle cryosections from normal, mdx, and dy/dy
mice with haematoxylin and eosin to outline the general
histological differences between these tissues . While normal
mouse skeletal muscle cells exhibit peripheral nucleation
(Fig . 5 a), mdxmouse skeletal muscle cells havemany cen-
trally localized nuclei (Fig. 5 b) which are a consequence of
the ongoing degeneration and regeneration occurring inmdx
muscle . Segmental necrosis of mdx skeletal muscle fibers
starts at -15 d of age and is followed by fiber regeneration
whereby regenerated fibers are characterized by central nu-
cleation (39) . In contrast, cryosections from dy/dy mouse
skeletal muscle exhibit muscle fibers with rounded contours,
marked variability of fiber size diameter, an increase of the
interstitial connective tissue, and many fibers with central
nucleation (Fig . 5 c) (6) . Staining of mouse cryosections
with fluorescein-labeled WGA demonstrated that mdx and
dy/dy mouse muscle exhibits comparable levels of WGA
binding components in the cell periphery when compared
with normal mouse muscle (Fig . 5, df) . These results agree
with the findings from the comparative immunoblot analysis
of Fig. 2, which illustrates anequal amount ofWGApositive
glycoproteins in muscle membranes from control and mdx
mice . Dystrophin antibodies labeled the entire cell periphery
1689Figure 4. Immunoblot analysis of DAPs in skeletal muscle mem-
branes from dy/dy mouse . Shown is a Coomassie blue-stained gel
and identical immunoblots labeled with rabbit antibodies to dystro-
phin (DYS) and DRP, mAb VIA4 1 to 156-DAG, as well as affinity-
purified sheep antibodies to 35-DAG, 43-DAG, 50-DAG, and 59-
DAP Lanes 1 and 2 consistofmembranes prepared from 10-wk-old
normal and dy/dy mouse skeletal muscle (250 ug protein/lane),
respectively . Components of the dystrophin-glycoprotein complex
are found with approximately equal abundance in normal and dy/dy
muscle membranes. Molecular weight standards (M x 10-3) are
indicated on the left .
of control and dy/dy skeletal muscle cryosections (Fig. 5, g
and i), illustrating normal distribution and abundance ofthis
sarcolemmal cytoskeleton protein in dystrophic muscle from
dy/dymouse . These results are in agreement with theimmu-
noblot analysis of Fig . 4, which shows that dystrophin is
present in normal size and abundance in skeletal muscle
membranes from dy/dy mouse . In contrast, mdx mouse
skeletal muscle fibers are completely missing dystrophin
(Fig . 5 h), which is a consequence of a point mutation in the
dystrophin gene (38) .
After this characterization, mouse skeletal muscle cryo-
sections were labeled with affinity-purified sheep antibodies
toDAPs (Fig . 6) . Immunofluorescence labeling ofDAPs was
restricted to the muscle cell periphery and the staining inten-
sity was comparable between normal and dy/dy skeletal
muscle (Fig . 6) . On the other hand, the immunofluorescence
staining intensity for 35-DAG, 43-DAG, 50-DAG, and 59-
DAP was greatly reduced in skeletal muscle fibers frommdx
mouse (Fig . 6) . Immunofluorescence labeling of the muscle
cell surface was not only markedly reduced but also occa-
sionally of a patchy nature, demonstrating that abundance
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and distribution ofDAGs is severely affected inmdx skeletal
muscle fibers. The fact that low levels ofDAPs are detectable
in the mdx muscle cell periphery by immunofluorescence
microscopy and mdx skeletal muscle membranes by immu-
noblotting suggests that the remaining DAPs are not present
in the cytoplasm but remain with themdx sarcolemmamem-
brane . DAGs were deficient inmdx skeletal muscle cryosec-
tions before, during, and after necrosis as revealed by im-
munofluorescence microscopy of similarly aged control and
mdx mice as used in the immunoblot analysis of Fig. 3. The
reduced density of 50-DAG in mdx skeletal muscle was
confirmed by immunofluorescence microscopy with mAb
IVD3 1 to 50-DAG (34) (results not shown) . Sheep antibod-
ies to 156-DAG did not exhibit strong enough immunofluo-
rescence labeling for a comparative analysis of skeletal mus-
cle cryosections from control, mdx, and dy/dy mice . In
agreement with the immunoblotting results ofFigs . 2 and 3
the findings from immunofluorescence microscopy indicate
that the suppressed density oftheseproteins is a consequence
of the absence of dystrophin in the mdx muscle . If the re-
duced amount ofDAPs would be independent of the status
ofdystrophin and due to secondary effects in skeletal muscle
degradation, one would also expect reduced levels ofDAPs
in dystrophic dy/dy skeletal muscle . This is not the case, as
illustrated by strong labeling of the dy/dy skeletal muscle
surface by antibodies to DAPs (Fig . 6) .
Discussion
The membrane cytoskeletal component dystrophin is tightly
associated to a large oligomeric complex containing several
sarcolemmal glycoproteins in skeletal muscle. A central
question of current muscular dystrophy research is how the
absence of dystrophin causes muscle cell necrosis . To learn
more about the early events in the molecular pathogenesis of
muscular dystrophy, here we investigated the relative abun-
dance of all of the components of the dystrophin-glyco-
protein complex in skeletal muscle membranes from mdx
mice, a dystrophin-deficient animal model forDMD which
exhibits necrotic skeletal muscle fibers . Immunoblot analy-
sis using total muscle membrane preparations and affinity-
purified antibodies was combined with data obtained by im-
munofluorescence microscopy. We have presented evidence
that the DAPs of apparent 35, 43, 50, 59, and 156 kD are
specifically and significantly reduced in skeletal muscle
from mdx mice . The major glycoprotein composition of
skeletal muscle fibers was not affected in mdx mice, which
indicates that the loss of glycoproteins in mdx mice is
specific for those glycoproteins that are normally linked to
dystrophin . Control experiments with dystrophin-containing
membranes from necrotic dy/dy mouse muscle exhibited a
normal abundance of DAPs, which demonstrates that the
loss ofthese proteins inmdx muscle is not caused by second-
ary effects of muscle degradation .
Itisknown from studies of other geneticdiseases involving
membrane cytoskeletal proteins, as well as enzyme or ion
channel complexes, that the deficiency in one subunit or
component of a complex can result in the loss of other
subunits or components of the protein complex . Hereditary
elliptocytosis, characterized by a defect in spectrin, is also
associated with deficiencies in protein-4 .1 and minor sialo-
glycoproteins (1) . Skeletal muscle phosphorylase kinase de-
1690FigureS. Characterization ofskeletal muscle cryosections from control, mdx, and dy/dy mice . Shown aretransverse cryosections ofnormal
(a, d, g), mdx (b, e, h), and dy/dy (c, f, t) mouse skeletal muscle stained with haematoxylin and eosin (a, b, c) and labeled with WGA
(d, e, f) and rabbit antisera to the COOH-terminal decapeptide of dystrophin (g, h, t) . Skeletal muscle from 10-wk-old mdx and dy/dy
mice exhibit comparable amounts ofWGAbinding components in the cell periphery when compared with skeletal muscle cryosections
from normal mice. Bar, 20 pin.
ficiency, which is caused by a single gene defect on the X
chromosome, is characterized by the combined loss of all
four subunits of this enzyme (12) . However, a generalized
loss of components in a protein complex is not observed in
the genetic disease muscular dysgenesis . This disorder re-
sults in a complete absence of skeletal muscle contraction
due to the failure of depolarization ofthe transverse tubular
membrane to trigger calcium release from sarcoplasmic re-
ticulum . Interestingly, only the a, subunit of the dihydro-
pyridine receptor is absent in dysgenic mice, while the az
subunit of the receptor is present (23) . Based on the variety
offindings for the molecularbasis ofgenetic disorders, itwas
not possible to conclude from our initial finding of greatly
reduced 156-DAG inmdx muscle (17) that all the other DAPs
are also affected in skeletal muscle fibers from mdx mice.
Consequently, highly specific antibodies to theDAPs had to
be developed to evaluate the status ofall components of the
dystrophin-glycoprotein complex in mdx muscle tissue .
The loss ofDAPs from the muscle cell surface could prin-
cipally occur in two different ways : (a) due to a decrease in
synthesis and/or assembly, or (b) due to an increase in degra-
dation . The absence ofdystrophin may result in the decrease
in synthesis ofDAPs similarly to that seen for phosphorylase
kinase subunits (12) . DAPs could be synthesized in normal
amounts but may not be properly assembled into an oligo-
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meric complex due to the lack of dystrophin . Both of these
possibilities could cause greatly reduced amounts ofDAPS in
skeletal muscle sarcolemma. On the other hand, DAPS may
be synthesized and assembled correctly, but due to the de-
ficiency in dystrophin, the membrane complex will lack the
proper interaction with the actin cytoskeleton . This could re-
sultin greatermobilityofthemembranecomplex, whichmay
render the protein components of the complex more vul-
nerable to degradation .
The molecular events that lead to muscle cell necrosis in
dystrophin-deficient muscle fibers and finally cause muscle
cell death have not yet been established . Membrane bio-
chemical studies demonstrated that dystrophin is a major
component of themembrane cytoskeleton of skeletal muscle
sarcolemma (32, 34) . By analogy to observations in other
cytoskeletal diseases (29, 44), dystrophin appears to be an
important structuralcomponent ofthe subsarcolemmal cyto-
skeleton . In addition, components of the dystrophin-gly-
coprotein complex could be important adhesion factors in
linking the subsarcolemmal actin cytoskeleton to an extra-
cellular glycoprotein of skeletal muscle fibers, as recently
suggested by an extensive biochemical and structural analy-
sis ofthe dystrophin-glycoprotein complex (16) . Dystrophin
and its 59-kD associated protein were identified as cytoskel-
etal elements which are tightly linked to a heteromeric inte-
169 1Figure 6. Distribution ofDAGs in normal, mdx, and dy/dy mouse skeletal muscle . Shown are transverse cryosections of skeletal muscle
from 10-wk-old normal (a, d, g, j), mdx (b, e, h, k), and dy/dy (c,f i, l) mice labeled with affinity-purified sheep antibodies to DAPs
35-DAG, 43-DAG, 50-DAG, and 59-DAP Immunofluorescence staining intensity for DAPs is greatly reduced inmdx skeletal muscle when
compared with skeletal muscle cryosections from normal and dy/dy mice . Bar, 20 um .
gralmembrane complex (16) . The DAGs of apparent 35, 43,
and 50kD were found to be the integral protein components
of the complex which spans the sarcolemma membrane,
while 156-DAG appears to be an extracellular glycoprotein
(16) . Disruption of the various components involved in the
structural link between subsarcolemmal cytoskeleton and an
extracellular glycoprotein may severely weaken the sarco-
lemmamembrane. This hypothesis is supported by the histo-
pathological finding thatDMD muscle fibers exhibit an early
separation between muscle cell surface and basal lamina
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(Bonilla, E ., and E . Moggio . 1986. Neurology. 36 [suppl 1] :
171) . Comprehensive analysisofDMD skeletal muscleshows
that muscle cell necrosis is preceded by a breakdown of the
plasma membrane (11, 15, 31) . Changes in muscle cell sur-
face morphology were observed in cultured skeletal muscle
cells from DMD patients and a decrease in basal lamina
components described (13) . These findings suggest that
deficiency in dystrophin and loss ofDAPsmay have second-
ary effects on components of the basal lamina . In addition,
skeletal muscle fibers frommdx mice exhibited an enhanced
1692vulnerability in contraction experiments, which may render
the sarcolemma more susceptible to suffering focal breaks
(43) . Recent findings demonstrated that skeletal muscle
fibers from mdx mouse are more fragile and have a decreased
osmotic stability (30).
In addition to beinga good animal model for studying seg-
mental necrosis in dystrophin-deficient skeletal muscle
fibers, mdx mice are currently being used to validate poten-
tial therapies for the replacement of dystrophin such as myo-
blast transfer therapy (35) or gene therapy (27). It will be
very important to determine the status of DAPs in skeletal
muscle fibers in which dystrophin has been replaced by these
experimental therapies. If the loss of DAPs is a significant
factor in muscle cell necrosis, then experimental therapies
will only succeed when, in addition to dystrophin, all DAPs
are restored.
In conclusion, we find that the density of DAPs is drasti-
cally suppressedin skeletal muscle membranes and cryosec-
tions from mdx mice. Our results strongly support the hy-
pothesis that the absence of dystrophin leads to a deficiency
in all ofthe DAPs. These findings, combined with results of
biochemical and structural analysis ofthe dystrophin-glyco-
protein complex (16), suggest that muscle fibers may be ren-
dered more susceptible to necrosis due to the loss of DAPs.
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